Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
S&P Global Offerings
Featured Topics
Featured Products
Events
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
Financial and Market intelligence
Fundamental & Alternative Datasets
Government & Defense
Banking & Capital Markets
Economy & Finance
Energy Transition & Sustainability
Technology & Innovation
Podcasts & Newsletters
12 Jan, 2021
By Drew Wilson
Permira Advisers LLC-backed Dr. Martens Ltd., the U.K.-based shoe brand, plans an IPO of at least 25% of the company on the London Stock Exchange, the Financial Times reported.
Private equity firm Permira invested in the company in 2013 and now holds an approximately 75% stake in the business, according to the report.
In the past, private equity giant Carlyle Group Inc. considered buying the shoe company, the report said, citing people familiar with the matter.
Goldman Sachs and Morgan Stanley have been hired as joint coordinators, while Barclays, HSBC, Merrill Lynch and RBC Europe are bookrunners, the report said. Lazard is a financial adviser to the company.